Piramal Enterprises has received approval to raise upto Rs 800 crore through issuance of Secured, Rated, Unlisted, Redeemable Non-Convertible Debentures (Debentures) on private placement basis. The Meeting of Administrative Committee (‘Committee’) of the Board of Directors held on October 24, 2023 approved the same.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.